Wednesday, July 23, 2014

EMPOWER Episode 3 - Pipeline Antidotes for Target Specific Oral Anticoagulants (TSOACs)

Listen to the podcast by clicking on the link below (link to iTunes here):

Show Notes:

Core content from this episode discussed in:
DiPiro's Pharmacotherapy, 9th Edition, Chapter 9
Goodman and Gilman's The Pharmacological Basis of Therapeutics, 12th Edition, Chapter 30

Published articles and references and ongoing trials related to pipeline antidotes for target specific oral anticoagulants discussed during this episode:

  • Aripazine (PER 977):
    • Data from Perosphere available here.  

Featured Post

Giapreza - A Closer Look at the Pharmacology of Ang2

Angiotensin-II (Ang2) is now an FDA approved vasopressor. With this new addition to the available options, experts are combing over the ...